NPPB and pulmonary arterial hypertension: The 2022 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension highlight NT-proBNP as a pivotal biomarker in evaluating right ventricular function and overall prognosis in PH patients [1].